- Home
- ADVB vs GTBP Comparison
ADVB vs GTBP Comparison
Compare ADVB & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ADVB | GTBP |
|---|---|---|
| Founded | 2014 | 1965 |
| Country | United States | United States |
| Employees | 31 | N/A |
| Industry | Medical Specialities | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.1M | 8.8M |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | ADVB | GTBP |
|---|---|---|
| Price | $3.71 | $0.42 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 23.4K | ★ 2.2M |
| Earning Date | 05-14-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3.75 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $1.26 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.19 | $0.26 |
| 52 Week High | $7.70 | $3.73 |
Technical Indicators
Market Signals| Indicator | ADVB | GTBP |
|---|---|---|
| Relative Strength Index (RSI) | 39.56 | 50.32 |
| Support Level | $3.73 | $0.39 |
| Resistance Level | $5.83 | $0.46 |
| Average True Range (ATR) | 0.53 | 0.05 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 3.03 | 38.72 |
Price Performance
Historical ComparisonAbout ADVB Advanced Biomed Inc.
Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.
About GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. The company is engaged in discovering, developing, and commercializing therapeutics from its proprietary product platform across various disease areas, mainly focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platform offers immuno-oncology products designed to treat hematologic malignancies, sarcoma, and solid tumors.